Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Dulman

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pediatric Blood & Cancer|June 4, 2019
Prospective longitudinal follow-up of children with sickle cell disease treated with hydroxyurea since infancyRonay Thomas, Robin Dulman, Angela Lewis, et al.
Pediatric Blood & Cancer|December 9, 2023
High hydroxyurea usage in sickle cell anemia regardless of patient demographicsVivian Phan, Ju Ae Park, Robin Dulman, et al.
European Journal of Haematology|July 11, 2022
Ten-year longitudinal analysis of hydroxyurea implementation in a pediatric sickle cell programVivian Phan, Ju Ae Park, Robin Dulman, et al.
Pediatric Hematology and Oncology|February 9, 2022
Robust immune responses to SARS-CoV-2 in a pediatric patient with B-Cell ALL receiving tisagenlecleucelOren M Gordon, Madeline Terpilowski, Robin Dulman, et al.
Pediatric Blood & Cancer|May 29, 2023
Effect of voxelotor on cardiopulmonary testing in youths with sickle cell anemia in a pilot studyVivian Phan, Jared Hershenson, Laura Caldarera, et al.
Haematologica|December 28, 2023
LNK/<i>SH2B3</i> as a novel driver in juvenile myelomonocytic leukemiaAstrid Wintering, Anna Hecht, Julia Meyer, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pediatric Blood & Cancer|June 4, 2019
Prospective longitudinal follow-up of children with sickle cell disease treated with hydroxyurea since infancyRonay Thomas, Robin Dulman, Angela Lewis, et al.
Pediatric Blood & Cancer|December 9, 2023
High hydroxyurea usage in sickle cell anemia regardless of patient demographicsVivian Phan, Ju Ae Park, Robin Dulman, et al.
European Journal of Haematology|July 11, 2022
Ten-year longitudinal analysis of hydroxyurea implementation in a pediatric sickle cell programVivian Phan, Ju Ae Park, Robin Dulman, et al.
Pediatric Hematology and Oncology|February 9, 2022
Robust immune responses to SARS-CoV-2 in a pediatric patient with B-Cell ALL receiving tisagenlecleucelOren M Gordon, Madeline Terpilowski, Robin Dulman, et al.
Pediatric Blood & Cancer|May 29, 2023
Effect of voxelotor on cardiopulmonary testing in youths with sickle cell anemia in a pilot studyVivian Phan, Jared Hershenson, Laura Caldarera, et al.
Haematologica|December 28, 2023
LNK/<i>SH2B3</i> as a novel driver in juvenile myelomonocytic leukemiaAstrid Wintering, Anna Hecht, Julia Meyer, et al.
Pageof 1